Recom-. G-5.
| National guideline recommendations for the treatment of cancer-related VTE | |||
| Recommendation | Grade | Level of evidence | Key references |
| LMWH is recommended in cases of VTE due to cancer. | Very strong recommendation (I) | A | Kakkos et al.[2] Ortel et al.[9] Kirkilesis et al.[23] |
| Use of DOAC (apixaban*, edoxaban, rivaroxaban) is recommended for the treatment of cancer-related VTE. | Very strong recommendation (I) | A | Kakkos et al.[2] Ortel et al.[9] Kirkilesis et al.[23] Agnelli et al.[27]Ageno et al.[28] |
| VTE: Venous thromboembolism; LMWH: Low molecular weight heparin; DOAC: Direct oral anticoagulant; * Apixaban may be preferred primarily in carefully selected patients with gastrointestinal system tumors. | |||